Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

ATP-sensitive potassium (K(ATP)) channels, so named because they are inhibited by intracellular (ATP), play key physiological roles in many tissues. In pancreatic beta cells, these channels regulate glucose-dependent insulin secretion and serve as the target for sulfonylurea drugs used to treat type 2 diabetes. This review focuses on insulin secretory disorders, such as congenital hyperinsulinemia and neonatal diabetes, that result from mutations in K(ATP) channel genes. It also considers the extent to which defective regulation of K(ATP) channel activity contributes to the etiology of type 2 diabetes.

Original publication




Journal article


J Clin Invest

Publication Date





2047 - 2058


ATP-Binding Cassette Transporters, Animals, Diabetes Mellitus, Type 2, Humans, Hyperinsulinism, Insulin, Islets of Langerhans, KATP Channels, Potassium Channels, Inwardly Rectifying, Sulfonylurea Compounds